Resonance Specialities Ltd

Resonance Specialities Ltd

₹ 154 5.00%
04 Aug 4:01 p.m.
About

Incorporated in 1989, Resonance Specialties Ltd manufactures Pyridine, Picoline, Cynopyridine and derivatives of the same[1]

Key Points

Business Overview:[1]
The Company manufactures and markets pyridine, pyridine derivatives, picolines, and bulk drugs, with pyridine and its derivatives constituting its primary source of revenue.

  • Market Cap 178 Cr.
  • Current Price 154
  • High / Low 154 / 77.0
  • Stock P/E 12.3
  • Book Value 63.4
  • Dividend Yield 0.65 %
  • ROCE 20.0 %
  • ROE 15.0 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Debtor days have improved from 83.3 to 56.2 days.

Cons

  • Company has a low return on equity of 10.9% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
13.46 10.14 15.34 16.36 17.30 18.06 18.24 24.20 21.27 21.53 22.96 24.48 32.58
11.87 9.22 14.02 15.31 15.22 15.71 16.35 19.95 18.72 19.17 19.51 18.84 25.12
Operating Profit 1.59 0.92 1.32 1.05 2.08 2.35 1.89 4.25 2.55 2.36 3.45 5.64 7.46
OPM % 11.81% 9.07% 8.60% 6.42% 12.02% 13.01% 10.36% 17.56% 11.99% 10.96% 15.03% 23.04% 22.90%
0.14 0.25 0.25 0.29 -0.64 0.45 0.30 0.07 0.23 0.35 0.32 0.74 0.54
Interest 0.07 0.09 0.11 0.12 0.10 0.10 0.08 0.03 0.08 0.06 0.05 0.05 0.01
Depreciation 0.35 0.36 0.38 0.37 0.48 0.49 0.48 0.11 0.33 0.33 0.34 0.34 0.34
Profit before tax 1.31 0.72 1.08 0.85 0.86 2.21 1.63 4.18 2.37 2.32 3.38 5.99 7.65
Tax % 33.59% 36.11% 11.11% 21.18% 31.40% 18.10% 31.90% 26.79% 31.22% 28.88% 26.04% 23.37% 24.97%
0.87 0.46 0.96 0.67 0.59 1.81 1.12 3.06 1.63 1.66 2.51 4.60 5.74
EPS in Rs 0.75 0.40 0.83 0.58 0.51 1.57 0.97 2.65 1.41 1.44 2.17 3.98 4.97
Raw PDF
Upcoming result date: today

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
38 39 34 36 41 56 70 76 58 55 78 90 102
37 36 32 35 37 48 56 59 51 50 67 76 83
Operating Profit 1 3 2 1 5 8 14 17 7 5 11 14 19
OPM % 3.3% 8% 6% 1.8% 12% 14% 20% 22% 12% 9% 14% 16% 19%
2 0 1 1 1 0 2 1 2 1 0 2 2
Interest 1 1 0 1 1 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 2 1 1 2 1 1
Profit before tax 1 2 1 0 5 7 15 16 7 4 9 14 19
Tax % 7% 28% 26% 2,700% 33% 20% 28% 24% 27% 25% 26% 26%
1 1 1 -1 3 6 11 12 5 3 7 10 15
EPS in Rs 1.11 1.03 0.89 -0.67 2.77 4.77 9.11 10.71 4.33 2.57 5.69 9.01 12.56
Dividend Payout % 45% 0% 0% 0% 0% 21% 11% 9% 23% 0% 18% 11%
Compounded Sales Growth
10 Years: 9%
5 Years: 5%
3 Years: 16%
TTM: 24%
Compounded Profit Growth
10 Years: 24%
5 Years: 0%
3 Years: 27%
TTM: 92%
Stock Price CAGR
10 Years: 19%
5 Years: -2%
3 Years: 17%
1 Year: 38%
Return on Equity
10 Years: 14%
5 Years: 13%
3 Years: 11%
Last Year: 15%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 12 12 12 12 12 12 12 12 12 12 12 12
Reserves 10 11 12 12 15 19 29 40 44 46 52 62
3 2 4 3 0 0 1 0 2 4 3 2
10 8 12 10 12 11 13 5 8 12 8 17
Total Liabilities 35 32 40 37 38 41 55 57 66 74 76 92
14 14 15 15 14 14 16 14 20 23 21 21
CWIP 0 0 0 1 1 2 0 0 0 0 1 4
Investments 0 0 0 0 0 0 1 0 0 3 0 12
20 18 25 22 23 25 38 42 45 48 54 57
Total Assets 35 32 40 37 38 41 55 57 66 74 76 92

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1 3 1 2 5 1 4 13 -8 4 -3 17
-0 -1 -3 -1 -0 -2 -1 -9 3 -7 4 -15
-2 -2 2 -1 -4 1 0 -2 1 0 -1 -2
Net Cash Flow -1 0 -0 0 1 1 3 3 -4 -2 -0 -0
Free Cash Flow 1 2 -2 1 5 -1 3 13 -16 -0 -4 14
CFO/OP 103% 122% 28% 362% 107% 47% 61% 110% -93% 117% -5% 141%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 99 66 80 68 67 40 49 40 78 89 105 56
Inventory Days 134 159 397 212 180 232 236 176 646 341 316 319
Days Payable 116 108 262 127 139 114 121 17 138 134 65 113
Cash Conversion Cycle 117 117 215 152 108 158 164 198 587 295 356 263
Working Capital Days 71 74 85 80 93 82 99 143 212 221 206 156
ROCE % 4% 9% 7% 2% 20% 31% 41% 35% 13% 7% 15% 20%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Electricity consumption per MT of production
Units/MT

Log in to view insights

Please log in to see hidden values.

Login
Export revenue as % of total revenue from operations
%
HSD (diesel) consumption per MT of production
Liters/MT
R&D expenditure as % of turnover
%
Number of permanent employees
count
Coal consumption per MT of production
MT/MT
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.25% 54.25% 54.25% 54.25% 54.25% 54.25% 54.25% 54.25% 54.25% 54.25% 54.25% 54.25%
0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 1.55%
45.74% 45.72% 45.71% 45.72% 45.71% 45.72% 45.72% 45.72% 45.71% 45.72% 45.72% 44.19%
No. of Shareholders 12,54711,94111,97311,85511,59911,72811,56011,52611,81011,51211,27210,998

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents